Arvinas (ARVN) Share-based Compensation (2017 - 2026)

Arvinas' (ARVN) quarterly Share-based Compensation came in at $12.1 million in Q1 2026, down 19.33% year-on-year from $15.0 million in Q1 2025, and up 42.35% quarter-over-quarter from $8.5 million in Q4 2025.

Arvinas (ARVN) Share-based Compensation (2017 - 2026) Analysis & Trends

Arvinas' Share-based Compensation history runs 10 years deep, the most recent figure standing at $12.1 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 19.33% year-over-year to $12.1 million in Q1 2026; TTM through Mar 2026 was $41.1 million, a 51.42% decrease from a year earlier, with the FY2025 full-year figure at $44.0 million, down 50.11% from the prior year.
  • Share-based Compensation grew to $12.1 million in Q1 2026 per ARVN's latest filing, from $8.5 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $24.7 million in Q3 2024 and bottomed at $8.5 million in Q4 2025.
  • The 5-year median for Share-based Compensation is $18.3 million (2023), against an average of $17.1 million.
  • Across the five-year window, Share-based Compensation surged 61.17% in 2022 and sank 63.52% in 2025, its largest moves.
  • Year by year, Share-based Compensation stood at $20.1 million in 2022, then fell by 16.92% to $16.7 million in 2023, then soared by 39.52% to $23.3 million in 2024, then tumbled by 63.52% to $8.5 million in 2025, then soared by 42.35% to $12.1 million in 2026.
  • Per Business Quant, the three latest ARVN Share-based Compensation figures stand at $12.1 million (Q1 2026), $8.5 million (Q4 2025), and $10.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Arvinas 519.68 Mn -95.22 Mn - 12.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.10 Mn
Mar 31, 2026 12.10 Mn
Dec 31, 2025 8.50 Mn
Dec 31, 2025 8.50 Mn
Sep 30, 2025 10.20 Mn
Sep 30, 2025 10.20 Mn
Jun 30, 2025 10.30 Mn
Jun 30, 2025 10.30 Mn
Mar 31, 2025 15.00 Mn
Mar 31, 2025 15.00 Mn
Dec 31, 2024 23.30 Mn
Dec 31, 2024 23.30 Mn
Sep 30, 2024 24.70 Mn
Sep 30, 2024 24.70 Mn
Jun 30, 2024 21.60 Mn
Jun 30, 2024 21.60 Mn
Mar 31, 2024 18.60 Mn
Mar 31, 2024 18.60 Mn
Dec 31, 2023 16.70 Mn
Dec 31, 2023 16.70 Mn